TTD | Drug: D04OTY

Drug General Information
Drug ID	D04OTY
Former ID	DIB001535
Drug Name	BFH-772
Synonyms	NVP-BFH-772
Indication	Psoriasis [ICD9: 696; ICD10:L40]		Phase 2	[523654]
Company	Novartis AG
Target and Pathway
Target(s)	VEGF receptor	Target Info	Agonist	[550850]
KEGG Pathway	Ras signaling pathway
	Rap1 signaling pathway
	Cytokine-cytokine receptor interaction
	HIF-1 signaling pathway
	Endocytosis
	PI3K-Akt signaling pathway
	Focal adhesion
	Transcriptional misregulation in cancer
	Rheumatoid arthritis
References
Ref 523654	ClinicalTrials.gov (NCT01449591) Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients. U.S. National Institutes of Health.
Ref 550850	CA patent application no. 841416, Method of selecting therapeutic indications.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

Drug Information